Key result
~87% of North Americans perceive postmortem genetic testing for young SCD as ineffective amid global unstandardization.
Why the study?
Investigation of sudden cardiac death in individuals aged 1-40 years commonly reveals a heritable cause, yet access to postmortem genetic testing remains variable.
Cross-Sectional (n=112)
Yes
Postmortem genetic testing for young sudden cardiac death is inconsistently available and lacks standardization globally, highlighting a need for improved access and multidisciplinary care.
Answers are grounded in this paper and cite their sources.
Global inconsistencies in postmortem genetic testing for young SCD support multidisciplinary standardization; leaves open prospective outcome studies before practice change.
Purpose Thorough investigation of sudden cardiac death (SCD) in those aged 1-40 years commonly reveals a heritable cause, yet access to postmortem genetic testing is variable. We explore practices of postmortem genetic testing and attitudes of healthcare professionals worldwide. Methods A survey was administered among healthcare professionals recruited through professional associations, social media and networks of researchers. Topics included practices around postmortem genetic testing, level of confidence in healthcare professionals’ ability, and attitudes towards postmortem genetic testing practices. Results There were 112 respondents, with 93% from North America, Europe and Australia and 7% from South America, Asia and Africa. Only 30% reported autopsy as mandatory, and overall practices were largely case-by-case and not standardised. North American respondents (87%) more often perceived practices as ineffective compared to those from Europe (58%) and Australia/New Zealand (48%, p= 0.002). Where a heritable cause is suspected, 69% considered postmortem genetic testing and 61% offered genetic counseling to surviving family members; financial resources varied widely. Half believed practices in their countries perpetuated health inequalities. Conclusion Postmortem genetic testing is not consistently available in the investigation of young SCD despite being a recommendation in international guidelines. Access to postmortem genetic testing, guided by well-resourced multidisciplinary teams, is critical in ascertaining a cause of death in many cases.
No takes yet. Share an insight, caveat, or question.
Heuvel et al. (2020) conducted a cross-sectional in Sudden cardiac death in the young (n=112). Postmortem genetic testing practices for sudden cardiac death in the young are largely unstandardized globally, with 87% of North American respondents perceiving them as ineffective compared to 58% in Europe.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: